^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    Myriapod® NGS BRCA1-2 panel CE IVD kit

    Company:
    Diatech Pharmacogenetics
    Type:
    CE-IVDR (New IVDR)
    Related tests:

    Details

    Evidence
    News
    Myriapod® NGS BRCA1-2 panel is a ready-to-use in-vitro diagnostic NGS solution for the detection of single nucleotide polymorphisms (SNV), insertions-deletions (indels) and copy number variation (CNV) of the BRCA1 and BRCA2 genes. The BRCA1-2 genes correlate with the genetic predisposition and response to targeted therapies in breast, ovarian, prostate and pancreatic cancers.
    Cancer:
    Breast Cancer, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer
    Gene:
    BRCA (Breast cancer early onset)
    Method:
    Next-generation sequencing